8-K/ALeadership Changes

BRISTOL MYERS SQUIBB CO 8-K/A Report, Executive Changes (Jan 13, 2006)

Filed January 13, 2006For Securities:BMYCELG-RIBMYMP

Summary

This Amendment No. 1 to Form 8-K for Bristol-Myers Squibb Company (BMY) provides an update regarding board committee appointments. Specifically, it confirms that Louis J. Freeh was appointed to the Audit Committee and the Committee on Directors and Corporate Governance on January 10, 2006. This appointment follows his initial naming to the Board of Directors, which was previously reported on September 13, 2005. For investors, this filing primarily signals ongoing governance adjustments within the company's board structure. The addition of a director to key committees like Audit and Corporate Governance can be viewed as a move towards strengthening oversight and compliance, especially in the context of corporate governance. Investors should monitor these committee assignments for insights into the company's commitment to good governance practices.

Key Highlights

  • 1Louis J. Freeh appointed to the Audit Committee of the Board of Directors.
  • 2Louis J. Freeh appointed to the Committee on Directors and Corporate Governance of the Board of Directors.
  • 3These committee appointments occurred on January 10, 2006.
  • 4This filing is an amendment to a previous 8-K filed on September 13, 2005.
  • 5The original 8-K reported Mr. Freeh's appointment to the Board of Directors on September 13, 2005.
  • 6The filing confirms ongoing governance activities at the board level.

Frequently Asked Questions

This filing, Amendment No. 1 to Form 8-K, primarily serves to report the appointment of Louis J. Freeh to two specific committees of Bristol-Myers Squibb's Board of Directors: the Audit Committee and the Committee on Directors and Corporate Governance.

The appointments of Louis J. Freeh to the Audit Committee and the Committee on Directors and Corporate Governance became effective on January 10, 2006.

No, this filing is an amendment that follows a previous report. Mr. Freeh was initially appointed to the Board of Directors on September 13, 2005, as previously disclosed in an 8-K filing on that date. This amendment details his subsequent committee assignments.

These appointments are important as they indicate ongoing governance developments. Membership on committees like the Audit Committee and the Committee on Directors and Corporate Governance suggests a focus on oversight, financial reporting integrity, and corporate governance best practices, which are key considerations for investors.